The study confirmed that Afqlir has equivalent efficacy and comparable safety to its reference medicine, Eylea.
Daily Wrap on MSN1h
Biden authorizes deeper Ukrainian strikes with US weaponsThe administration of President Joe Biden has granted Ukraine permission to use American weapons against targets deep inside ...
The European Commission has finalised its shortlist but lawmakers fear they have no time to grill candidates this year. View ...
Discover why the iShares MSCI Spain ETF (EWP) is a promising investment with strong potential for growth in Spain's robust ...
The European Union has expanded sanctions against Iran, targeting the Islamic republic of Iran shipping lines and its ...
The European Commission has conducted unannounced antitrust inspections in the data centre construction sector, it said in a ...
Russia's full-scale invasion of Ukraine reaches its 1,000th day on Tuesday, a grim milestone in Europe's deadliest conflict ...
A trade agreement between the European Union and Mercosur countries, which includes a significant section on agriculture, has ...
French farmers are mobilizing for widespread protests Monday, targeting the controversial EU-Mercosur trade agreement.
Taiwan President Lai Ching-te called on Monday for the signing of an economic partnership agreement with the European Union, ...
The European Union has widened its sanctions against Iran over Tehran's support of Russia in its war with Ukraine, the ...
Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer and full approval earlier this year, was the key asset in AbbVie's $10.1 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback